Gliptin therapy reduces hepatic and myocardial fat in type 2 diabetic patients
Sign Up to like & getrecommendations! Published in 2017 at "European Journal of Clinical Investigation"
DOI: 10.1111/eci.12817
Abstract: Increased hepatic fat and cardiac fat are common in patients with type 2 diabetes mellitus (T2DM) and are associated with a greater risk of liver fibrosis and cardiovascular (CV) events. Sex‐specific differences of dipeptidyl peptidase‐four… read more here.
Keywords: reduces hepatic; fat; gliptin therapy; hepatic myocardial ... See more keywords